These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis. Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773 [TBL] [Abstract][Full Text] [Related]
23. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. Horstkotte D; Schulte H; Bircks W; Strauer B J Heart Valve Dis; 1993 May; 2(3):291-301. PubMed ID: 8269122 [TBL] [Abstract][Full Text] [Related]
24. Late results of valve replacement with the Björk-Shiley valve (1973 to 1982). Orszulak TA; Schaff HV; DeSmet JM; Danielson GK; Pluth JR; Puga FJ J Thorac Cardiovasc Surg; 1993 Feb; 105(2):302-12. PubMed ID: 8429659 [TBL] [Abstract][Full Text] [Related]
25. Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. A three-year experience. Nicoloff DM; Emery RW; Arom KV; Northrup WF; Jorgensen CR; Wang Y; Lindsay WG J Thorac Cardiovasc Surg; 1981 Nov; 82(5):674-83. PubMed ID: 7300400 [TBL] [Abstract][Full Text] [Related]
26. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement. Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256 [TBL] [Abstract][Full Text] [Related]
27. Aspirin anticoagulation in children with mechanical aortic valves. Verrier ED; Tranbaugh RF; Soifer SJ; Yee ES; Turley K; Ebert PA J Thorac Cardiovasc Surg; 1986 Dec; 92(6):1013-20. PubMed ID: 3784585 [TBL] [Abstract][Full Text] [Related]
28. Incidence of emboli with cloth-covered Starr-Edwards valve without anticoagulation and with varying forms of anticoagulation. Analysis of 183 patients followed for 3 1/2 years. Moggio RA; Hammond GL; Stansel HC; Glenn WW J Thorac Cardiovasc Surg; 1978 Feb; 75(2):296-9. PubMed ID: 625136 [TBL] [Abstract][Full Text] [Related]
29. Twenty-year comparison of tissue and mechanical valve replacement. Khan SS; Trento A; DeRobertis M; Kass RM; Sandhu M; Czer LS; Blanche C; Raissi S; Fontana GP; Cheng W; Chaux A; Matloff JM J Thorac Cardiovasc Surg; 2001 Aug; 122(2):257-69. PubMed ID: 11479498 [TBL] [Abstract][Full Text] [Related]
30. Risk-benefit analysis of warfarin therapy in Hancock mitral valve replacement. Hill JD; LaFollette L; Szarnicki RJ; Avery GJ; Wilson RM; Gerbode F; Kerth WJ; Rodvien R J Thorac Cardiovasc Surg; 1982 May; 83(5):718-23. PubMed ID: 6978975 [TBL] [Abstract][Full Text] [Related]
33. [Late complications following Björk-Shiley and St. Jude Medical heart valve replacement]. Horstkotte D; Körfer R; Budde T; Haerten K; Schulte HD; Bircks W; Loogen F Z Kardiol; 1983 May; 72(5):251-61. PubMed ID: 6880335 [TBL] [Abstract][Full Text] [Related]
34. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement. Stewart S; Cianciotta D; Alexson C; Manning J J Thorac Cardiovasc Surg; 1987 Apr; 93(4):551-4. PubMed ID: 3561002 [TBL] [Abstract][Full Text] [Related]
35. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED; J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973 [TBL] [Abstract][Full Text] [Related]
36. Mechanical versus biological valve prosthesis in the mitral position: a 10-year follow up of St. Jude Medical and Biocor valves. Demirag M; Kirali K; Omeroglu SN; Mansuroglu D; Akinci E; Ipek G; Berki T; Gürbüz A; Isik O; Yakut C J Heart Valve Dis; 2001 Jan; 10(1):78-83. PubMed ID: 11206772 [TBL] [Abstract][Full Text] [Related]
37. Decision-making in the choice of heart valve for replacement in patients aged 60-70 years: twenty-year follow up of the St. Jude Medical aortic valve prosthesis. Emery RW; Arom KV; Kshettry VR; Kroshus TJ; Von R; Kersten TE; Lillehei TJ; Nicoloff DM; Erickson CA J Heart Valve Dis; 2002 Jan; 11 Suppl 1():S37-44. PubMed ID: 11843519 [TBL] [Abstract][Full Text] [Related]
38. Long-term comparative analysis of the Björk-Shiley and Hancock valves implanted in 1975. Martinell J; Fraile J; Artiz V; Moreno J; Rábago G J Thorac Cardiovasc Surg; 1985 Nov; 90(5):741-9. PubMed ID: 4058046 [TBL] [Abstract][Full Text] [Related]
39. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704 [TBL] [Abstract][Full Text] [Related]
40. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study. Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]